# OnCo record idea-reg-olanzapine-cachexia-global-confirmation (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-reg-olanzapine-cachexia-global-confirmation/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-reg-olanzapine-cachexia-global-confirmation" ;
  schema:name "Confirm low-dose olanzapine for appetite and weight in advanced cancer worldwide"@en ;
  schema:description "A randomised placebo-controlled trial at Tata Memorial found that 2.5 mg of olanzapine daily, a cheap antipsychotic pill already used for chemotherapy nausea, improved appetite and weight gain in patients starting chemotherapy for advanced stomach, lung and hepatopancreatobiliary cancers. A multinational confirmatory trial is needed before guidelines and labels adopt it."@en ;
  schema:url <https://onco.cc/ideas/idea-reg-olanzapine-cachexia-global-confirmation/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.3332/ecancer.2014.442> ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:institutions <https://onco.cc/institutions/tata-memorial/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-cachexia-supportive/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-pantziarka-ecancermedicalscience/> .